Dr John Parker Joins PeriGen as Chief Medical Officer, Bringing Expertise to Advance Maternal and Infant Healthcare

PeriGen Inc, the market leader in FDA-cleared AI-based maternal-fetal early warning systems today announced the addition of John Parker, M.D., as the company’s new Chief Medical Officer.

Dr John Parker will work closely with PeriGen’s client base to optimize use of the company’s analytics for patient care and research. He will also be instrumental in informing product development and regulatory affairs as PeriGen continues to expand its product suite and associated services.

Dr. Parker joins PeriGen from OhioHealth, where he served in leadership roles in perinatal quality and as associate program director of the residency program at Riverside Methodist Hospital, the busiest labor and delivery hospital in the state of Ohio. He has 16 years of experience in obstetrics and gynecology.

Parker started his career in software development, serving as a developer, designer, sales support engineer, and consultant before deciding to pursue medicine. “John is a bit of a unicorn given his knowledge of systems design and development and practical experience as a physician leader and educator,” said Matthew Sappern, PeriGen CEO. “He is exceptional at helping PeriGen clients understand how to best leverage PeriGen analytics within their workflow.”

SourcePeriGen

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.